Qualigen therapeutics to present five posters at the american association for cancer research annual meeting 2023

Carlsbad, calif., march 15, 2023 (globe newswire) -- qualigen therapeutics, inc. (“qualigen” or “the company,” nasdaq: qlgn), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for orphan drug designation, while also commercializing diagnostics, today announces the company will be presenting five posters at the american association for cancer research (aacr) annual meeting 2023 to be held april 14-19 in orlando, fl. the aacr conference is a focal point of the cancer research community, where scientists, clinicians, other healthcare professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine.
QLGN Ratings Summary
QLGN Quant Ranking